Acetylcysteine

Acetylcysteine Reactions 1664, p17 - 12 Aug 2017 Clinical deterioration of ethylmalonic encephalopathy: case report A 29-year-old woman experienced clinical deterioration of ethylmalonic encephalopathy during treatment with acetylcysteine [N-acetylcysteine]. She had a history of ethylmalonic encephalopathy and was started on acetylcysteine [dose and route not stated]. However, she experienced clinical worsening of ethylmalonic encephalopathy. Therefore, after eight months, the treatment with acetylcysteine was stopped and her condition was fully reversed. Author comment: "The treatment trial with [acetylcysteine] was aborted after 8 months due to clinical deterioration fully reversible after ending [acetylcysteine] intake." "This case expands the known phenotype and prompts caution regarding [acetylcysteine] therapy in atypical ethylmalonic encephalopathy." Neuhofer C, et al. A new phenotype of ethylmalonic encephalopathy. European Journal of Neurology 24 (Suppl. 1): 505 abstr. PR1105, Jul 2017. Available from: URL: http://doi.org/10.1111/ene.13368 [abstract] - Germany 803263365 0114-9954/17/1664-0001/$14.95 Adis © 2017 Springer International Publishing AG. All rights reserved Reactions 12 Aug 2017 No. 1664 http://www.deepdyve.com/assets/images/DeepDyve-Logo-lg.png Reactions Weekly Springer Journals

Acetylcysteine

Reactions Weekly , Volume 1664 (1) – Aug 12, 2017
Free
1 page
Loading next page...
1 Page
 
/lp/springer_journal/acetylcysteine-eRf7LRu7ia
Publisher
Springer International Publishing
Copyright
Copyright © 2017 by Springer International Publishing AG
Subject
Medicine & Public Health; Drug Safety and Pharmacovigilance; Pharmacology/Toxicology
ISSN
0114-9954
eISSN
1179-2051
D.O.I.
10.1007/s40278-017-34297-0
Publisher site
See Article on Publisher Site

Abstract

Reactions 1664, p17 - 12 Aug 2017 Clinical deterioration of ethylmalonic encephalopathy: case report A 29-year-old woman experienced clinical deterioration of ethylmalonic encephalopathy during treatment with acetylcysteine [N-acetylcysteine]. She had a history of ethylmalonic encephalopathy and was started on acetylcysteine [dose and route not stated]. However, she experienced clinical worsening of ethylmalonic encephalopathy. Therefore, after eight months, the treatment with acetylcysteine was stopped and her condition was fully reversed. Author comment: "The treatment trial with [acetylcysteine] was aborted after 8 months due to clinical deterioration fully reversible after ending [acetylcysteine] intake." "This case expands the known phenotype and prompts caution regarding [acetylcysteine] therapy in atypical ethylmalonic encephalopathy." Neuhofer C, et al. A new phenotype of ethylmalonic encephalopathy. European Journal of Neurology 24 (Suppl. 1): 505 abstr. PR1105, Jul 2017. Available from: URL: http://doi.org/10.1111/ene.13368 [abstract] - Germany 803263365 0114-9954/17/1664-0001/$14.95 Adis © 2017 Springer International Publishing AG. All rights reserved Reactions 12 Aug 2017 No. 1664

Journal

Reactions WeeklySpringer Journals

Published: Aug 12, 2017

There are no references for this article.

You’re reading a free preview. Subscribe to read the entire article.


DeepDyve is your
personal research library

It’s your single place to instantly
discover and read the research
that matters to you.

Enjoy affordable access to
over 18 million articles from more than
15,000 peer-reviewed journals.

All for just $49/month

Explore the DeepDyve Library

Search

Query the DeepDyve database, plus search all of PubMed and Google Scholar seamlessly

Organize

Save any article or search result from DeepDyve, PubMed, and Google Scholar... all in one place.

Access

Get unlimited, online access to over 18 million full-text articles from more than 15,000 scientific journals.

Your journals are on DeepDyve

Read from thousands of the leading scholarly journals from SpringerNature, Elsevier, Wiley-Blackwell, Oxford University Press and more.

All the latest content is available, no embargo periods.

See the journals in your area

DeepDyve

Freelancer

DeepDyve

Pro

Price

FREE

$49/month
$360/year

Save searches from
Google Scholar,
PubMed

Create lists to
organize your research

Export lists, citations

Read DeepDyve articles

Abstract access only

Unlimited access to over
18 million full-text articles

Print

20 pages / month

PDF Discount

20% off